Candel Therapeutics Inc (CADL) — Financial Flexibility Index
Candel Therapeutics Inc (CADL) has a Financial Flexibility Index of -0.27x as of March 2026. Free cash flow of $-17.36 Million (operating CF $-18.04 Million minus capex $675.00K) represents 0% of total liabilities ($63.89 Million). Check Candel Therapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Candel Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Candel Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see Candel Therapeutics Inc cash flow conversion.
Annual Financial Flexibility Index for Candel Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Candel Therapeutics Inc. Explore CADL cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.51x | $-37.72 Million | $-38.31 Million | $73.27 Million | ▲ +22.7% |
| 2024 | -0.67x | $-27.01 Million | $-27.02 Million | $40.54 Million | ▲ +43.9% |
| 2023 | -1.19x | $-33.79 Million | $-34.24 Million | $28.46 Million | ▼ -21.4% |
| 2022 | -0.98x | $-30.12 Million | $-31.42 Million | $30.80 Million | ▼ -20.3% |
| 2021 | -0.81x | $-20.38 Million | $-22.22 Million | $25.07 Million | ▼ -562.1% |
| 2020 | -0.12x | $-7.59 Million | $-9.07 Million | $61.84 Million | ▼ -32.0% |
| 2019 | -0.09x | $-5.02 Million | $-5.18 Million | $53.94 Million | — |